Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about ARGX
Recent news which mentions ARGX
< Previous
1
2
3
4
5
6
7
8
Next >
Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays.
June 05, 2023
Tickers
ABBV
ALNY
AMGN
ARGX
Tags
GILD
GSK
BMY
From
MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023
May 31, 2023
Tickers
ACNB
AKBA
AMBA
AMX
Tags
Initiation
ASLN
PRCT
From
Benzinga
Expert Ratings for argenx
May 31, 2023
Tickers
ARGX
Tags
Benzinga
BZI/AAR
ARGX
From
Benzinga
Booking Holdings To Rally Around 18%? Here Are 10 Other Analyst Forecasts For Friday
May 05, 2023
Tickers
AAPL
ARGX
BILL
BKNG
Tags
YELP
AAPL
News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2023
April 25, 2023
Tickers
AFL
APLM
ARGX
BSRR
Tags
CHK
UHS
ESTE
From
Benzinga
Analyst Ratings for argenx
April 21, 2023
Tickers
ARGX
Tags
Benzinga
BZI/AAR
ARGX
From
Benzinga
7 Biotech Stocks That Could Cure Your Portfolio Woes
April 19, 2023
Tickers
ARGX
BGNE
BMRN
INCY
Tags
Stocks to Buy
Market News
LEGN
From
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
April 12, 2023
Tickers
APLS
ARGX
ASND
CTIC
Tags
ILMN
TGTX
NVO
From
Benzinga
A Bearish Sign Appears On argenx's Chart
March 23, 2023
Tickers
ARGX
Tags
BZI/CROSS
Market News
Movers
From
Benzinga
Analyst Ratings for argenx
March 20, 2023
Tickers
ARGX
Tags
Benzinga
BZI/AAR
Market News
From
Benzinga
Analyst Boosts Immunovant Price Target After Updated Pipeline Realignment
March 20, 2023
Tickers
ARGX
IMVT
Tags
Trading Ideas
ARGX
Analyst Ratings
From
Benzinga
5 Analysts Have This to Say About argenx
March 03, 2023
Tickers
ARGX
Tags
ARGX
Market News
Analyst Ratings
From
Benzinga
Earnings Outlook For argenx
March 01, 2023
Tickers
ARGX
Tags
ARGX
BZI/EP
Market News
From
Benzinga
Immunovant Could Potentially Be An M&A Target, Writes Analyst
February 15, 2023
Tickers
ARGX
IMVT
JNJ
ROIV
Tags
Health Care
Price Target
ROIV
From
Benzinga
Analyst Ratings for argenx
January 10, 2023
Tickers
ARGX
Tags
Analyst Ratings
Market News
ARGX
From
Benzinga
AT&T To Rally Over 15%? Here Are 10 Other Analyst Forecasts For Tuesday
January 10, 2023
Tickers
ALLY
ARGX
ARHS
FIVE
Tags
News
MIRM
Price Target
From
Benzinga
Alphabet To $115? Here Are 10 Other Price Target Changes For Thursday
December 22, 2022
Tickers
AGCO
AMGN
ARGX
ARQQ
Tags
AMGN
ZYME
AGCO
From
Benzinga
Analyst Ratings for argenx
December 07, 2022
Tickers
ARGX
Tags
Benzinga
BZI/AAR
ARGX
From
Benzinga
Expert Ratings for argenx
December 07, 2022
Tickers
ARGX
Tags
Benzinga
BZI/AAR
ARGX
From
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 01, 2022
Tickers
ABC
ACGL
ACM
ADP
Tags
CMC
CASY
EFXT
From
Benzinga
Bluebird Bio Sells Priority Review Voucher For $102M, Strengthening Its Financial Position
November 30, 2022
Tickers
ARGX
BLUE
Tags
BLUE
Benzinga
Small Cap
From
Benzinga
Argenx's Flagship Neuromuscular Treatment For Subcutaneous Injection Goes Under Priority FDA Review
November 22, 2022
Tickers
ARGX
HALO
Tags
HALO
News
General
From
Benzinga
McDonald's To Rally Over 13%? Here Are 5 Other Price Target Changes For Friday
October 28, 2022
Tickers
AMZN
ARGX
ESS
EXLS
Tags
Benzinga
Markets
AMZN
From
Benzinga
Recap: argenx Q3 Earnings
October 27, 2022
Tickers
ARGX
Tags
BZI/Recaps
ARGX
Market News
From
Benzinga
7 Analysts Have This to Say About argenx
October 18, 2022
Tickers
ARGX
Tags
Benzinga
BZI/AAR
ARGX
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
October 12, 2022
Tickers
ABT
ARGX
ATEC
AXNX
Tags
PGY
BZI/Ratings
TW
From
Benzinga
Immunovant's New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say
September 29, 2022
Tickers
ARGX
IMVT
JNJ
ROIV
Tags
Analyst Ratings
Briefs
Biotech
From
Benzinga
Argenx Seeks FDA Nod For Its Flagship Neuromuscular Treatment Formulated For Subcutaneous Injection
September 21, 2022
Tickers
ARGX
HALO
Tags
General
News
HALO
From
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 11, 2022
Tickers
ALXO
ARGX
GRPH
LHDX
Tags
LHDX
ARGX
ALXO
From
Benzinga
Argenx Gets European Marketing Authorization For Neuromuscular Disorder Candidate
August 11, 2022
Tickers
ARGX
Tags
Benzinga
ARGX
Health Care
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit